Cargando…

OR11-001 - Protein misfolding in mevalonate kinase deficiency

Detalles Bibliográficos
Autores principales:	Stojanov, S, Gersting, SW, Reitzle, L, Reiß, D, Belohradsky, BH, Vogeser, M, Maier, B, Teupser, D, Muntau, AC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952567/ http://dx.doi.org/10.1186/1546-0096-11-S1-A190

Ejemplares similares

PW03-021 - HSCT in mevalonate kinase deficiency
por: Wolska-Kuśnierz, B, et al.
Publicado: (2013)

Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1
por: Barroso, Madalena, et al.
Publicado: (2023)

PW02-020 - Colitis revealing mevalonate kinase deficiency
por: Michael, L, et al.
Publicado: (2013)

Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening
por: Maier, Esther M., et al.
Publicado: (2009)

P03-007 - Mevalonate kinase gene in Behçet’s disease
por: Tas, D Arslan, et al.
Publicado: (2013)

The Domain-Specific and Temperature-Dependent Protein Misfolding Phenotype of Variant Medium-Chain acyl-CoA Dehydrogenase
por: Jank, Johanna M., et al.
Publicado: (2014)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006)

Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
por: Shinar, Y, et al.
Publicado: (2015)

Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
por: Rafiq, Nadia K., et al.
Publicado: (2018)

Mevalonate kinase deficiency: current perspectives
por: Favier, Leslie A, et al.
Publicado: (2016)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Weekly oral alendronate in mevalonate kinase deficiency
por: Cantarini, Luca, et al.
Publicado: (2013)

Isolated neurological presentations of mevalonate kinase deficiency
por: Hoytema van Konijnenburg, Eva M. M., et al.
Publicado: (2022)

PReS-FINAL-2335: Preliminary analysis of 85 patients with mevalonate kinase deficiency from the eurofever registry
por: Ter Haar, N, et al.
Publicado: (2013)

Mevalonate kinase deficiency and IBD: shared genetic background
por: Bianco, Anna Monica, et al.
Publicado: (2014)

Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra
por: Peciuliene, Skaiste, et al.
Publicado: (2016)

Management of Mevalonate Kinase Deficiency: A Pediatric Perspective
por: Jeyaratnam, Jerold, et al.
Publicado: (2020)

Mevalonate kinase deficiency: an early onset inflammatory bowel disease?
por: Martins, A, et al.
Publicado: (2015)

OR3-001 – RIP2 kinase is activated in Blau Syndrome and IBD
por: Foley, KP, et al.
Publicado: (2013)

Diagnostic value of urinary mevalonic acid excretion in patietns with a clinical suspicion of mevalonate kinase deficiency (MKD)
por: Jeyaratnam, J, et al.
Publicado: (2015)

Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency
por: Ruiz-Ortiz, E, et al.
Publicado: (2015)

A case of neonatal sweet syndrome associated with mevalonate kinase deficiency
por: Irwin, Margaret, et al.
Publicado: (2023)

Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis
por: Tricarico, Paola Maura, et al.
Publicado: (2013)

Natural history of mevalonate kinase deficiency: a literature review
por: Zhang, Shumin
Publicado: (2016)

Genetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency
por: Jeyaratnam, J, et al.
Publicado: (2015)

Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases
por: Jurczyluk, Julie, et al.
Publicado: (2016)

Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
por: Politiek, Frouwkje A., et al.
Publicado: (2021)

Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency
por: Henneman, L., et al.
Publicado: (2010)

Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study
por: Tricarico, Paola Maura, et al.
Publicado: (2013)

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?
por: Mulders-Manders, C. M., et al.
Publicado: (2015)

Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency()
por: Bifulco, Maurizio
Publicado: (2015)

Febrile attacks triggered by milk allergy in an infant with mevalonate kinase deficiency
por: Nakashimai, Hideyuki, et al.
Publicado: (2016)

Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency
por: Munoz, Marcia A., et al.
Publicado: (2019)

The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency
por: Jeyaratnam, Jerold, et al.
Publicado: (2022)

Two Siblings With Recurrent Fevers: The Path to Mevalonate Kinase Deficiency Diagnosis
por: Pereira-Nunes, Joana, et al.
Publicado: (2023)

Efficacy of Anakinra Treatment in two Moroccan Patients With Mevalonate Kinase Deficiency
por: Souali, Manal, et al.
Publicado: (2023)

Inborn errors of metabolism and the human interactome: a systems medicine approach
por: Woidy, Mathias, et al.
Publicado: (2018)

OR5-001 – Characterization of tonsil infiltration in PFAPA
por: Chiesa, S, et al.
Publicado: (2013)

PReS-FINAL-2212: Mevalonate kinase deficiency: different faces with separate treatments
por: Gençpınar, P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jf2jktpo3blgk7ukt6em69kc1j